ICJIM
Intercontinental Journal of Internal Medicine

The Intercontinental Journal of Internal Medicine aims to publish issues related to all fields of internal medicine of the highest scientific and clinical value at an international level and accepts articles on these topics.

eISSN: 2980-0846
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
SIADH-associated hyponatremia in hospitalized COVID-19 patients: relationship with ınflammatory and stress response markers
Abstract
Aims: Hyponatremia observed during the course of COVID-19 infection is closely associated with disease prognosis. The objective of this study is to determine the prevalence of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) in patients diagnosed with COVID-19 and to analyze the relationship between this condition and inflammatory markers and stress response parameters.
Methods: The study included 50 patients hospitalized with a diagnosis of COVID-19 who were found to have hyponatremia (Na<135 mEq/L). The diagnosis of SIADH was based on the criteria of clinical euvolemia, low plasma osmolarity (<275 mOsm/kg), and high urinary sodium (>40 mEq/L). TSH and cortisol levels were evaluated to rule out secondary causes in the differential diagnosis. Patients were divided into two groups: SIADH-positive (n=37) and non-SIADH (n=13). The Mann-Whitney U test was used for intergroup comparisons, and the Spearman test was used for correlation analyses.
Results: The mean age of the patients was 62.1±12.3 years, and a higher proportion of female patients was observed in the SIADH group (p=0.038). Serum sodium levels (median: 130.0 mEq/L) were significantly lower in the SIADH (+) group compared to the Non-SIADH group (p<0.01). Among inflammatory markers, ferritin levels were found to be significantly higher in the SIADH group (741.0 vs 335.0 ng/mL; p=0.029), and serum cortisol levels were also found to be markedly elevated in this group (7.5 vs 1.6 µg/dl; p=0.017). In the correlation analysis, a significant negative correlation was found between serum sodium levels and cortisol (r=-0.325, p=0.021) and ferritin (r=-0.284, p=0.046).
Conclusion: The primary etiological factor for COVID-19-associated hyponatremia is SIADH. Elevated ferritin and cortisol levels accompanying this condition indicate that systemic inflammation and the stress response are associated with the severity of hyponatremia. Preserved urinary sodium and elevated cortisol levels are key clinical clues supporting the diagnosis of SIADH in the course of COVID-19.

Keywords : COVID-19, SIADH, hyponatremia, ferritin, cortisol

Download Article


1. World Health Organization. Clinical management of COVID-19: living guideline, 23 June 2022 [Internet]. World Health Organization; 2022.
2. Fu L, Wang B, Yuan T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect. 2020;80(6):656-665. <a href="https://doi.org/10.1016/j.jinf.2020.03.041">doi:10.1016/j.jinf.2020.03.041</a>
3. Frontera JA, Valdes E, Huang J, et al. Prevalence and impact of hyponatremia in patients with coronavirus disease 2019 in New York City. Crit Care Med. 2020;48(12):e1211-e1217. <a href="https://doi.org/10.1097/CCM.0000000000004605">doi:10.1097/CCM.0000000000004605</a>
4. Berni A, Malandrino D, Parenti G, Maggi M, Poggesi L, Peri A. Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together? J Endocrinol Invest. 2020;43(8):1137-1139. <a href="https://doi.org/10.1007/s40618-020-01301-w">doi:10.1007/s40618-020-01301-w</a>
5. Yousaf Z, Al-Shokri SD, Al-Soub H, Mohamed MFH. COVID-19-associated SIADH: a clue in the times of pandemic! Am J Physiol Endocrinol Metab. 2020;318(6):E882-E885. <a href="https://doi.org/10.1152/ajpendo.00178.2020">doi:10.1152/ajpendo.00178.2020</a>
6. Habib MB, Sardar S, Sajid J. Acute symptomatic hyponatremia in setting of SIADH as an isolated presentation of COVID-19. IDCases. 2020;21:e00859. <a href="https://doi.org/10.1016/j.idcr.2020.e00859">doi:10.1016/j.idcr.2020.e00859</a>
7. Khidir RJY, Ibrahim BAY, Adam MHM, et al. Prevalence and outcomes of hyponatremia among COVID-19 patients: a systematic review and meta-analysis. Int J Health Sci (Qassim). 2022;16(5):69-84.
8. Gheorghe G, Ilie M, Bungau S, Stoian AMP, Bacalbasa N, Diaconu CC. Is there a relationship between COVID-19 and hyponatremia?Medicina (Kaunas). 2021;57(1):55. <a href="https://doi.org/10.3390/medicina57010055">doi:10.3390/medicina57010055</a>
9. Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342(21): 1581-1589. <a href="https://doi.org/10.1056/NEJM200005253422107">doi:10.1056/NEJM200005253422107</a>
10. Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations.Am J Med. 2013;126(10 Suppl 1):S1-S42. <a href="https://doi.org/10.1016/j.amjmed.2013.07.006">doi:10.1016/j.amjmed.2013.07.006</a>
11. Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356(20):2064-2072. <a href="https://doi.org/10.1056/NEJMcp066837">doi:10.1056/NEJMcp066837</a>
12. Sheikh MM, Ahmad E, Jeelani HM, Riaz A, Muneeb A. COVID-19 pneumonia: an emerging cause of syndrome of inappropriate antidiuretic hormone. Cureus. 2020;12(6):e8841. <a href="https://doi.org/10.7759/cureus.8841">doi:10.7759/cureus.8841</a>
13. Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021-1028. <a href="https://doi.org/10.1515/cclm-2020-0369">doi:10.1515/cclm-2020-0369</a>
14. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834-847. <a href="https://doi.org/10.1002/ajh.25829">doi:10.1002/ajh.25829</a>
15. Garrahy A, Thompson CJ. Hyponatremia and glucocorticoid deficiency. Front Horm Res. 2019;52: 80-92. <a href="https://doi.org/10.1159/000493239">doi:10.1159/000493239</a>
16. Machiraju PK, Alex NM, Safinaaz, Vadamalai V. Hyponatremia in coronavirus disease-19 patients: a retrospective analysis. Can J Kidney Health Dis. 2021;8:20543581211067069. <a href="https://doi.org/10.1177/20543581211067069">doi:10.1177/20543581211067069</a>
17. Tzoulis P, Waung JA, Bagkeris E, et al. Dysnatremia is a predictor for morbidity and mortality in hospitalized patients with COVID-19.J Clin Endocrinol Metab. 2021;106(6):1637-1648. <a href="https://doi.org/10.1210/clinem/dgab107">doi:10.1210/clinem/dgab107</a>
18. Tezcan ME, Dogan Gokce G, Sen N, Zorlutuna Kaymak N, Ozer RS. Baseline electrolyte abnormalities would be related to poor prognosis in hospitalized coronavirus disease 2019 patients.New Microbes New Infect. 2020;37:100753. <a href="https://doi.org/10.1016/j.nmni.2020.100753">doi:10.1016/j.nmni.2020.100753</a>
19. Lippi G, South AM, Henry BM. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Ann Clin Biochem. 2020; 57(3):262-265. <a href="https://doi.org/10.1177/0004563220922255">doi:10.1177/0004563220922255</a>
20. Ayat P, Alam S, Capric V, Chen J, McFarlane SI. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) with severe hyponatremia as the initial and sole presentation of COVID-19 infection: a case report and pathophysiologic insights. Cureus. 2023;15(1):e34161. <a href="https://doi.org/10.7759/cureus.34161">doi:10.7759/cureus.34161</a>
21. Kurian SJ, Mathews SP, Paul A, et al. Association of serum ferritin with severity and clinical outcome in COVID-19 patients: an observational study in a tertiary healthcare facility. Clin Epidemiol Glob Health. 2023; 21:101295. <a href="https://doi.org/10.1016/j.cegh.2023.101295">doi:10.1016/j.cegh.2023.101295</a>
22. Yazdanpanah P, Vafaei F, Afrouz S. Diagnosis of coronavirus disease 2019 by potential laboratory factors. J Clinic Care Skill. 2022;3(4):149-154.
23. Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020;43(7):1027-1031. <a href="https://doi.org/10.1007/s40618-020-01276-8">doi:10.1007/s40618-020-01276-8</a>
24. Jensterle M, Herman R, Janez A, et al. The relationship between COVID-19 and hypothalamic-pituitary-adrenal axis: a large spectrum from glucocorticoid insufficiency to excess-the CAPISCO international expert panel. Int J Mol Sci. 2022;23(13):7326. <a href="https://doi.org/10.3390/ijms23137326">doi:10.3390/ijms23137326</a>
25. Hasanvand A. COVID-19 and the role of cytokines in this disease. Inflammopharmacology. 2022;30(3):789-798. <a href="https://doi.org/10.1007/s10787-022-00992-2">doi:10.1007/s10787-022-00992-2</a>
26. Adekanmbi O, Ilesanmi O, Idowu O, et al. Characteristics and outcomes of patients hospitalized with COVID-19 at a tertiary hospital in Nigeria. Afr Health Sci. 2023;23(1):72-82. <a href="https://doi.org/10.4314/ahs.v23i1.9">doi:10.4314/ahs.v23i1.9</a>
Article available in :
Volume 4, Issue 3, 2026
Page : 60-64
https://doi.org/10.51271/ICJIM-0078
Article Information
Received : 21 May 2026
Accepted : 05 Ağu 2026
Published : 31 Ağu 2026
Corresponding Author :

Murat Alay: Department of Endocrinology, Faculty of Medicine, Van Yüzüncü Yıl University, Van, Turkiye

[email protected]
Citation : Özgökçe O, Alay M. SIADH-associated hyponatremia in hospitalized COVID-19 patients: relationship with inflammatory and stress response markers. Intercont J Int Med. 2026;4(3):60-64. doi:10.51271/ICJIM-0078

Read: 4
Download : 10
Cited: 0
_Footer